Mepolizumab for Eosinophilic COPD
There has been a lot of interest in biologics, which are focused on the cytokines that modify eosinophil biology in asthma. We have seen a number of studies in the past 2 years and the approval of molecules that target the eosinophilic phenotype in asthma.